Efficacy of daratumumab in patients with amyloid light-chain amyloidosis achieving deep responses
Latest Information Update: 14 Dec 2019
At a glance
- Drugs Daratumumab (Primary) ; Dexamethasone (Primary)
- Indications Amyloid light-chain amyloidosis
- Focus Therapeutic Use
Most Recent Events
- 14 Dec 2019 New trial record
- 10 Dec 2019 Results presented at the 61st Annual Meeting and Exposition of the American Society of Hematology